Xudong Li

A new pre-emptive TKIs strategy for preventing relapse based on BCR/ABL monitoring for Ph+ALL undergoing allo-HCT: a prospective clinical cohort study

Jie-yu Ye, D. Nie, Li-ping Ma, 2020, Leukemia.

Effect of sorafenib maintenance on Epstein-Barr virus and cytomegalovirus infections in patients with FLT3-ITD AML undergoing allogeneic hematopoietic stem cell transplantation: a secondary analysis of a randomized clinical trial

Yu Wang, S. Tu, Yan Chen, 2022, BMC Medicine.

Diagnosis and treatment for the early stage of cytomegalovirus infection during hematopoietic stem cell transplantation

Kui Zhao, B. Long, Xiangzhong Zhang, 2022, Frontiers in Immunology.

Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial

Shunqing Wang, Shuangfeng Xie, H. Qu, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial.

S. Tu, Yu Wang, Yan Chen, 2020, The Lancet. Oncology.

Idarubicin plus BuCy versus BuCy conditioning regimens for intermediate‐risk acute myeloid leukemia in first complete remission undergoing auto‐HSCT: An open‐label, multicenter, randomized phase 3 trial

Zhi-xiang Wang, F. Huang, L. Xuan, 2023, American journal of hematology.

Sorafenib maintenance after allogeneic haemopoietic stem-cell transplantation in patients with FLT3-ITD acute myeloid leukaemia: long-term follow-up of an open-label, multicentre, randomised, phase 3 trial.

Yu Wang, S. Tu, Yan Chen, 2023, The Lancet. Haematology.

Impact of genetic patterns on sorafenib efficacy in patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation: a multi-center, cohort study

Yu Wang, S. Tu, Yan Chen, 2023, Signal transduction and targeted therapy.